ClinicalTrials.Veeva

Menu
P

Perpetual Succour Hospital | Cebu Cancer Institute - Oncology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pregabalin
Bevacizumab
Farletuzumab
Pegcetacoplan
Taxane
Tofacitinib
ANX005
Azvudine
Platinum
Adalimumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 14 total trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling
Atrial Fibrillation
Drug: Apixaban Placebo
Drug: Milvexian

A Phase II/III Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection...

Enrolling
SARS-CoV-2 Infection
Drug: Azvudine
Drug: Placebo

Trial sponsors

Viatris logo
A
A
Fresenius Kabi logo
Genentech logo
H
Ipsen logo
Janssen (J&J Innovative Medicine) logo
Merck KGaA (EMD Serono) logo
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems